Gilmore Neil O'Neill
CIK 1742084 · CEO · last filed 2026-06-05
Gilmore Neil O'Neill is a CEO who has filed 28 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider sold $41.5K of EDIT on Jun 5, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $828.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$828.2K
4
28
-$1.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EDIT | CEO | 248,313 | $2.50 | $620.8K | -$1.00M | 15 | 2026-06-05 |
| Unity Biotechnology, Inc. (UBX) Delisted | Director | — | $0.20 | — | $0 | 5 | 2024-06-21 |
| Aptinyx Inc. (APTX) Delisted | Director | — | $0.06 | — | $0 | 2 | 2022-05-31 |
| SRPT | EVP, R&D & CMO | 13,546 | $15.31 | $207.4K | $0 | 6 | 2021-03-10 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | EDIT | Sell (S) | −15,380 | -$41.5K | EDGAR |
| 2026-03-16 | EDIT | Grant (A) | — | $0 | EDGAR |
| 2026-03-04 | EDIT | Sell (S) | −5,394 | -$10.9K | EDGAR |
| 2025-12-04 | EDIT | Sell (S) | −5,603 | -$12.1K | EDGAR |
| 2025-09-04 | EDIT | Sell (S) | −5,592 | -$14.5K | EDGAR |
| 2025-06-04 | EDIT | Sell (S) | −15,192 | -$26.2K | EDGAR |
| 2025-03-27 | EDIT | Grant (A) | — | $0 | EDGAR |
| 2025-03-05 | EDIT | Sell (S) | −16,632 | -$28.5K | EDGAR |
| 2024-12-05 | EDIT | Sell (S) | −1,618 | -$3.4K | EDGAR |
| 2024-09-06 | EDIT | Sell (S) | −1,555 | -$5.3K | EDGAR |